One-year clinical outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL study
Ulrich Schäfer(Universität Hamburg), Lenard Conradi, Tobias Schmidt(Asklepios Fachklinikum Brandenburg), Christian Frerker(University Hospital Schleswig-Holstein), Martin Landt, Christian Butter(University of Zurich), Hendrik Treede(Universität Hamburg), Abdelhakim Allali(Segeberger Kliniken), Efstratios I. Charitos(University of Bonn), Olga Nikolayevska, Johannes Schirmer(Universität Hamburg), Cornel Koban
Cited by 3
Related Papers
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients
|Circulation|2001|626
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
|European Heart Journal|2018|377
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
|Journal of the American College of Cardiology|2017|331